4 min read

Digital Recruitment Solutions

Whether your goal is the first patient randomized in a new study, or meeting the study enrollment goal, or a target number of sites activated.
Read where the next wave of innovation in research recruitment and engagement is headed.

With summer behind us, many of our clients are focused on year-end milestones. Whether your goal is the first patient randomized in a new study, or meeting the study enrollment goal, or a target number of sites activated, online marketing can be integrated into your strategy to help make recruitment a success this fall. Read on to learn how the right digital patient recruitment solutions can help support your traditional recruitment campaigns.

Driving Traffic with Social Media
Among 1,165 trial volunteers surveyed, almost two-thirds reported that information found online influenced their decision to join a clinical trial.1 The advantage of using social media is that it can be easily integrated with alternative recruitment channels, including email, online display, and traditional advertising campaigns.

Sponsors are increasingly turning to platforms like Facebook (by creating a study specific page) and Twitter as a way to target potential patients, due to the engagement opportunities and targeting capabilities they offer. If you choose to run social media campaigns for your program, it is important to re-visit your metrics regularly and evaluate the campaign’s performance. UBC is able to help monitor your campaign metrics and interpret them to make sure your time and budget are being used effectively.

A central social media campaign may not be the right fit for your study. You may need to look at alternate routes. Remember that social media can also be deployed through your study sites. With an estimated 2.3 billion social media users now online across the globe,2 it is likely that your study sites have either a Facebook or a Twitter account of their own. By working together with your study sites, you can post trial messages to their social media platforms, reaching the target population for your trial. To help pave the way for sites, and reduce site burden, it is key to provide them suitable versions of IRB-approved print and online ads so site staff can post content to their social media pages.

Call to Action
If your advertising campaigns are not receiving the expected response and/or causing site burden due to extra time spent screening potential participants, you may want to explore text-messaging screening.

A text message campaign may not be the solution for every recruitment challenge faced. Although, for the right study design and patient population, text messaging may help speed up your recruitment response. We have learned that the rate of referrals to sites doubled after adding text messaging to a print, TV, and radio campaign for a trial.3

How does it work? The user texts a keyword (found on viewed advertising) to a local number, electing to receive the text screener. This prompts a series of study-specific pre-screening questions. The study candidate can then be directed to a recruitment call center, or directly to the site in their local area for further screening. By using their own smartphone, text response lends to discretion, convenience, and quick action, not to mention, a more patient-centric approach.

Want to learn more about UBC’s digital engagement and patient recruitment solutions for clinical trials?

Click here for more information about UBC’s Patient & Physician Recruitment & Retention services, or contact us.

1 “Using Social Media in Clinical Trial Recruitment,” FDA News 2015
2 Source: StatCounter, Q1 2016.
3 Source: Internal UBC patient recruitment case study, 2016

Other Recent Posts

Featured Image
Press
3 min read

UBC Appoints Dr. Massoud Toussi as Vice President, Real World Evidence

UBC welcomes Massoud Toussi as its new Vice President of Real-World Evidence. Toussi brings over 20 years of experience spanning pharma, CROs, and regulatory work. He's authored more than 50 publications and contributed to scientific standards through ENCePP, ISPE, ISPOR, and other key organizations.
The acquisition strengthens UBC’s leadership in evidence generation offerings with globally recognized expertise in HEOR, medical affairs and market access.
Press
4 min read

UBC Acquires Evidinno Outcomes Research, Expanding Real-World Evidence and HEOR Capabilities

United BioSource LLC (UBC) has acquired Evidinno Outcomes Research Inc., a Vancouver-based healthcare research consulting firm specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and advanced statistical and economic analysis.
nanotechnology and abstract graphene structures
Press
6 min read

Datavant and UBC Partner to Transform Observational Research and Patient Access for Biopharmaceutical Sponsors

Datavant and United BioSource Corporation (UBC) have joined forces to transform late-phase research and patient access programs for biopharmaceutical sponsors. By combining Datavant’s privacy-first data connectivity with UBC’s expertise in specialty therapies, the partnership introduces two new offerings: Modern Observational Research Study Designs and Enhanced Patient Access Programs. These solutions aim to accelerate evidence generation, improve patient outcomes, and set a new standard for real-world research and access.
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.